Counterpath Corp (CPAH) Stock Price, Quote, News and Overview
NASDAQ:CPAH - Nasdaq -
CPAH Quote, Performance and Key Statistics
NASDAQ:CPAH (2/26/2021, 4:30:01 PM)
3.48
+0.02 (+0.43%)
The current stock price of CPAH is 3.48 null. In the past month the price increased by 2.35%. In the past year, price increased by 67.31%.
About CPAH
Company Profile
CounterPath, Corp. focuses on the design, development, marketing and sales of desktop and mobile application software, conferencing server software, gateway server software and related professional services, such as pre and post sales technical support and customization services. The Company's software products are sold into the telecommunications sector, specifically the voice over Internet protocol, unified communications and fixed-mobile convergence markets. The company's product suite includes SIP-based softphones, server applications and Fixed Mobile Convergence solutions that enable service providers, enterprises and Original Equipment Manufacturers to cost-effectively integrate voice, video, presence and Instant Messaging applications into their VoIP offerings and extend functionality across both fixed and mobile networks. This company is covered under both TSX and NYSE as V.CCV and CPAH respectively.
Company Info
Counterpath Corp
300-505 BURRARD STREET
VANCOUVER A1 V7X 1M3
CEO: David Karp
Phone: 604-320-3344
Counterpath Corp / CPAH FAQ
What is the stock price of Counterpath Corp today?
The current stock price of CPAH is 3.48 null. The price increased by 0.43% in the last trading session.
What is the ticker symbol for Counterpath Corp stock?
The exchange symbol of Counterpath Corp is CPAH and it is listed on the Nasdaq exchange.
On which exchange is CPAH stock listed?
CPAH stock is listed on the Nasdaq exchange.
What is Counterpath Corp worth?
Counterpath Corp (CPAH) has a market capitalization of 22.41M null. This makes CPAH a Nano Cap stock.
What are the support and resistance levels for Counterpath Corp (CPAH) stock?
Counterpath Corp (CPAH) has a support level at 3.47 and a resistance level at 3.5. Check the full technical report for a detailed analysis of CPAH support and resistance levels.
Should I buy Counterpath Corp (CPAH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CPAH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CPAH, evaluating the profitability, health, valuation and growth aspects
- Counterpath Corp (CPAH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Counterpath Corp (CPAH) Sales and EPS estimates to see what analysts future expectations are.
- Counterpath Corp (CPAH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Counterpath Corp (CPAH) Insider and Institutional Ownership to learn about the owners and their transactions.
- Counterpath Corp (CPAH) Stock Chart to make your own analysis
- Counterpath Corp (CPAH) Latest news and press-releases to stay up to date.
Does Counterpath Corp (CPAH) stock pay dividends?
CPAH does not pay a dividend.
What is the Price/Earnings (PE) ratio of Counterpath Corp (CPAH)?
The PE ratio for Counterpath Corp (CPAH) is 34.8. This is based on the reported non-GAAP earnings per share of 0.1 and the current share price of 3.48 null. Check the full fundamental report for a full analysis of the valuation metrics for CPAH.
CPAH Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to CPAH. When comparing the yearly performance of all stocks, CPAH is one of the better performing stocks in the market, outperforming 82.07% of all stocks.
CPAH Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CPAH. CPAH has a medium profitability rating, but doesn't score so well on its financial health evaluation.
CPAH Financial Highlights
Over the last trailing twelve months CPAH reported a non-GAAP Earnings per Share(EPS) of 0.1. The EPS increased by 116.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.3% | ||
| ROA | 5.43% | ||
| ROE | 18.26% | ||
| Debt/Equity | 0 |
CPAH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to CPAH. The Buy consensus is the average rating of analysts ratings from 1 analysts.